2019
DOI: 10.1101/831594
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

The human α-defensin-derived peptide HD5(1-9) inhibits cellular attachment and entry of human cytomegalovirus

Abstract: AUTHOR SUMMARY 49Defensins are peptides produced by various human organs which take part in the 50 natural defense against pathogens. Recently, it has been shown that defensins are 51 further cleaved to smaller peptides that have high intrinsic anti-microbial activity. We 52 here challenged the hypothesis that these peptides might have antiviral activity, and due 53 to their presumably natural occurrence, low toxicity. Indeed, we found one peptide 54 fragment that turned out to block the attachment of the huma… Show more

Help me understand this report
View published versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2021
2021
2021
2021

Publication Types

Select...
2

Relationship

1
1

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 40 publications
0
2
0
Order By: Relevance
“…In the case of parainfluenza respiratory virus, the temporin G-mediated blocking of the late steps of viral replication impairs the extracellular release of viral particles. The human α-defensin-derived peptide HD5(1–9) is also able to prevent viral infection by inhibiting the adherence and the subsequent entry of the virus into cells [ 195 ]. Cathelicidin-derived AMP GF-17 and BMAP-18 inhibit ZIKV through directly inactivating the virus and interfering with the interferon (IFN) pathway [ 196 ].…”
Section: Activity Of Ampsmentioning
confidence: 99%
“…In the case of parainfluenza respiratory virus, the temporin G-mediated blocking of the late steps of viral replication impairs the extracellular release of viral particles. The human α-defensin-derived peptide HD5(1–9) is also able to prevent viral infection by inhibiting the adherence and the subsequent entry of the virus into cells [ 195 ]. Cathelicidin-derived AMP GF-17 and BMAP-18 inhibit ZIKV through directly inactivating the virus and interfering with the interferon (IFN) pathway [ 196 ].…”
Section: Activity Of Ampsmentioning
confidence: 99%
“…The clinical HCMV isolates H2497 and H1873 were isolated from amniotic fluid of two HCMV-infected but antiviral-naive pregnant women and primarily isolated from ARPE-19 cells without any prior fibroblast adaption ( 69 ).…”
Section: Methodsmentioning
confidence: 99%